Single nucleotide polymorphisms in the multidrug resistance gene 1 (ABCB1): Effects on its expression and clinicopathological characteristics in breast cancer patients

Pharmacogenetics and Genomics

Volumn 18, Issue 3, 2008, Pages 263-273

  Vaclavikova, Radka ^a   Nordgard, Silje H ^d,e   Alnaes, Grethe I G ^d,e   Hubackova, Miluse ^a   Kubala, Eugen ^b   Kodet, Roman ^c   Mrhalova, Marcela ^c   Novotny, Jan ^c   Gut, Ivan ^a   Kristensen, Vessela N ^d,e   Soucek, Pavel ^a  

^a NATIONAL INSTITUTE OF PUBLIC HEALTH   (Czech Republic)

^b UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

^c CHARLES UNIVERSITY   (Czech Republic)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

^e UNIVERSITY OF OSLO   (Norway)

Author keywords

ABCB1; Breast; Cancer; Expression; Genotyping; Marker; Microarray

Indexed keywords

ESTROGEN RECEPTOR; GLYCOPROTEIN P; MULTIDRUG RESISTANCE PROTEIN 1;

ADULT; ALLELE; ANALYSIS OF VARIANCE; ARTICLE; BREAST CANCER; CANCER PATIENT; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; EXON; FISHER EXACT TEST; GENE EXPRESSION; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MICROARRAY ANALYSIS; MULTIDRUG RESISTANCE; PATHOLOGY; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; STUDENT T TEST;

ADULT; AGED; ALLELES; BASE SEQUENCE; BREAST NEOPLASMS; DNA PRIMERS; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE FREQUENCY; HUMANS; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; P-GLYCOPROTEIN; PHARMACOGENETICS; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; RECEPTORS, ESTROGEN; RNA, MESSENGER; RNA, NEOPLASM;

EID: 40049090206     PISSN: 17446872     EISSN: 17446880     Source Type: Journal    
DOI: 10.1097/FPC.0b013e3282f60a91     Document Type: Article

References (46)

1. Gottesman MM, Pastan I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem 1993; 62:385-427.
2. Leonessa F, Clarke R. ATP binding cassette transporters and drug resistance in breast cancer. Endocr Relat Cancer 2003; 10:43-73.
3. Callen DF, Baker E, Simmers RN, Seshadri R, Roninson IB. Localization of the human multiple drug resistance gene, ABCB1, to 7q21.1. Hum Genet 1987; 77:142-144.
4. Sakaeda T, Nakamura T, Okumura K. Pharmacogenetics of drug transporters and its impact on the pharmacotherapy. Curr Top Med Chem 2004; 4:1385-1398.
5. Ling V. Multidrug resistance: molecular mechanisms and clinical relevance. Cancer Chemother Pharmacol 1997; 40:S3-S8.
6. Thiebaut F, Tsuruo T, Hamada H, Gottesman MM, Pastan I, Willingham MC. Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proc Natl Acad Sci U S A 1987; 84:7735-7738.
7. Ro J, Sahin A, Ro JY, Fritsche H, Hortobagyi G, Blick M. Immunohistochemical analysis of P-glycoprotein expression correlated with chemotherapy resistance in locally advanced breast cancer. Hum Pathol 1990; 21:787-791.
8. Arnal M, Franco N, Fargeot P, Riedinger JM, Brunet-Lecomte P, Lizard-Nacol S. Enhancement of ABCB1 gene expression in normal tissue adjacent to advanced breast cancer. Breast Cancer Res Treat 2000; 61:13-20.
9. Charpin C, Vielh P, Duffaud F, Devictor B, Andrac L, Lavaut MN, et al. Quantitative immunocytochemical assays of P-glycoprotein in breast carcinomas: correlation to messenger RNA expression and to immunohistochemical prognostic indicators. J Natl Cancer Inst 1994; 86:1539-1545.
10. Schneider J, Gonzalez-Roces S, Pollan M, Lucas R, Tejerina A, Martin M, et al. Expression of LRP and ABCB1 in locally advanced breast cancer predicts axillary node invasion at the time of rescue mastectomy after induction chemotherapy. Breast Cancer Res 2001; 3:183-191.
11. Burger H, Foekens JA, Look MP, Meijer-van Gelder ME, Klijn JG, Wiemer EA, et al. RNA expression of breast cancer resistance protein, lung resistance-related protein, multidrug resistance-associated proteins 1 and 2, and multidrug resistance gene 1 in breast cancer: correlation with chemotherapeutic response. Clin Cancer Res 2003; 9:827-836.
12. Surowiak P, Materna V, Matkowski R, Szczuraszek K, Kornafel J, Wojnar A, et al. Relationship between the expression of cyclooxygenase 2 and ABCB1/P-glycoprotein in invasive breast cancers and their prognostic significance. Breast Cancer Res 2005; 7:R862-R870.
13. Chintamani, Singh JP, Mittal MK, Saxena S, Bansal A, Bhatia A, et al. Role of P-glycoprotein expression in predicting response to neoadjuvant chemotherapy in breast cancer - a prospective clinical study. World J Surg Oncol 2005; 3:61.
14. Larkin A, O'Driscoll L, Kennedy S, Purcell R, Moran E, Crown J, et al. Investigation of MRP-1 protein and MDR-1 P-glycoprotein expression in invasive breast cancer: a prognostic study. Int J Cancer 2004; 112:286-294.
15. Moureau-Zabotto L, Ricci S, Lefranc JP, Coulet F, Genestie C, Antoine M, et al. Prognostic impact of multidrug resistance gene expression on the management of breast cancer in the context of adjuvant therapy based on a series of 171 patients. Br J Cancer 2006; 94:473-480.
16. Kroetz DL, Pauli-Magnus C, Hodges LM, Huang CC, Kawamoto M, Johns SJ, et al. Sequence diversity and haplotype structure in the human ABCB1 (ABCB1, Multidrug resistance transporter) gene. Pharmacogenetics 2003; 13:481-494.
17. Kimchi-Sarfaty C, Oh JM, Kim IW, Sauna ZE, Calcagno AM, Ambudkar SV, Gottesman MM. A 'silent' polymorphism in the MDR1 gene changes substrate specificity. Science 2007; 315:525-528.
18. Komar AA. Silent SNPs: impact on gene function and phenotype. Pharmacogenomics 2007; 8:1075-1080.
19. Hoffmeyer S, Burk O, von Richter O, Arnold HP, Brockmoller J, Johne A, et al. Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc Natl Acad Sci U S A 2000; 97:3473-3478.
20. Kerb R. Implications of genetic polymorphisms in drug transporters for pharmacotherapy. Cancer Lett 2006; 234:4-33.
21. Illmer T, Schuler US, Thiede C, Schwarz UI, Kim RB, Gotthard S, et al. ABCB1 gene polymorphisms affect therapy outcome in acute myeloid leukemia patients. Cancer Res 2002; 62:4955-4962.
22. Kafka A, Sauer G, Jaeger C, Grundmann R, Kreienberg R, Zeillinger R, et al. Polymorphism C3435T of the MDR1 gene predicts response to preoperative chemotherapy in locally advanced breast cancer. Int J Oncol 2003; 22:1117-1121.
23. Jamroziak K, Balcerczak E, Cebula B, Kowalczyk M, Panczyk M, Janus A, et al. Multi-drug transporter ABCB1 gene polymorphism and prognosis in adult acute lymphoblastic leukemia. Pharmacol Rep 2005; 57:882-888.
24. Goto M, Masuda S, Saito H, Uemoto S, Kiuchi T, Tanaka K, et al. C3435T polymorphism in the ABCB1 gene affects the enterocyte expression level of CYP3A4 rather than Pgp in recipients of living-donor liver transplantation. Pharmacogenetics 2002; 12:451-457.
25. Obata H, Yahata T, Quan J, Sekine M, Tanaka K. Association between single nucleotide polymorphisms of drug resistance-associated genes and response to chemotherapy in advanced ovarian cancer. Anticancer Res 2006; 26:2227-2232.
26. Soucek P, Anzenbacher P, Skoumalova I, Dvorak M. Expression of cytochrome P450 genes in CD34+ hematopoietic stem and progenitor cells. Stem Cells 2005; 23:1417-1422.
27. Jung M, Ramankulov A, Roigas J, Johannsen M, Ringsdorf M, Kristiansen G, Jung K. In search of suitable reference genes for gene expression studies of human renal cell carcinoma by real-time PCR. BMC Mol Biol 2007; 8:47.
28. Weidenhammer EM, Kahl BF, Wang L, Wang L, Duhon M, Jackson JA, et al. Multiplexed, targeted gene expression profiling and genetic analysis on electronic microarrays. Clin Chem 2002; 48:1873-1882.
29. Huang Y, Shirajian J, Schroder A, Yao Z, Summers T, Hodko D, et al. Multiple sample amplification and genotyping integrated on a single electronic microarray. Electrophoresis 2004; 25:3106-3116.
30. Erali M, Schmidt B, Lyon E, Witwer C. Evaluation of electronic microarrays for genotyping factor V, factor II, and MTHFR. Clin Chem 2003; 49:732-739.
31. Cascorbi I, Gerloff T, Johne A, Meisel C, Hoffmeyer S, Schwab M, et al. Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter ABCB1 gene in white subjects. Clin Pharmacol Ther 2001; 69:169-174. Erratum in: Clin Pharmacol Ther 2004; 75:124.
32. Gaikovitch EA, Cascorbi I, Mrozikiewicz PM, Brockmoller J, Frotschl R, Kopke K, et al. Polymorphisms of drug-metabolizing enzymes CYP2C9, CYP2C19, CYP2D6, CYP1A1, NAT2 and of P-glycoprotein in a Russian population. Eur J Clin Pharmacol 2003; 59:303-312.
33. Bernal ML, Sinues B, Fanlo A, Mayayo E. Frequency distribution of C3435T mutation in exon 26 of the ABCB1 gene in a Spanish population. Ther Drug Monit 2003; 25:107-111.
34. Jamroziak K, Balcerczak E, Mlynarski W, Mirowski M, Robak T. Distribution of allelic variants of functional C3435T polymorphism of drug transporter ABCB1 gene in a sample of Polish population. Pol J Pharmacol 2002; 54:495-500.
35. Sarmanova J, Tynkova L, Susova S, Gut I, Soucek P. Genetic polymorphisms of biotransformation enzymes: allele frequencies in the population of the Czech Republic. Pharmacogenetics 2000; 10:781-788. Erratum in: Pharmacogenetics 2003; 13:243.
36. Nobili S, Landini I, Giglioni B, Mini E. Pharmacological strategies for overcoming multidrug resistance. Curr Drug Targets 2006; 7:861-879.
37. Owen A, Chandler B, Bray PG, Ward SA, Hart CA, Back DJ, et al. Functional correlation of P-glycoprotein expression and genotype with expression of the human immunodeficiency virus type 1 coreceptor CXCR4. J Virol 2004; 78:12022-12029.
38. Wang D, Johnson AD, Papp AC, Kroetz DL, Sadee W. Multidrug resistance polypeptide 1 (ABCB1, ABCB1) variant 3435C > T affects mRNA stability. Pharmacogenet Genomics 2005; 15:693-704.
39. Meissner K, Jedlitschky G, Meyer zu Schwabedissen H, Dazert P, Eckel L, Vogelgesang S, et al. Modulation of multidrug resistance P-glycoprotein 1 (ABCB1) expression in human heart by hereditary polymorphisms. Pharmacogenetics 2004; 14:381-385.
40. Oselin K, Nowakowski-Gashaw I, Mrozikiewicz PM, Wolbergs D, Pahkla R, Roots I. Quantitative determination of ABCB1 mRNA expression in peripheral blood lymphocytes: a possible role of genetic polymorphisms in the ABCB1 gene. Eur J Clin Invest 2003; 33:261-267.
41. Nordgard SH, Ritchie MD, Jensrud SD, Motsinger AA, Alnaes GI, Lemmon G, et al. ABCB1 and GST polymorphisms associated with TP53 status in breast cancer. Pharmacogenet Genomics 2007; 17:127-136.
42. Tang K, Wong LP, Lee EJ, Chong SS, Lee CG. Genomic evidence for recent positive selection at the human ABCB1 gene locus. Hum Mol Genet 2004; 13:783-797.
43. Turgut S, Yaren A, Kursunluoglu R, Turgut G. MDR1 C3435T polymorphism in patients with breast cancer. Arch Med Res 2007; 38:539-544.
44. Seymour L, Bezwoda WR, Dansey RD. P-glycoprotein immunostaining correlates with ER and with high Ki67 expression but fails to predict anthracycline resistance in patients with advanced Breast cancer. Breast Cancer Res Treat 1995; 36:61-69.
45. Lacave R, Coulet F, Ricci S, Touboul E, Flahault A, Rateau JG, et al. Comparative evaluation by semiquantitative reverse transcriptase polymerase chain reaction of ABCB1, MRP and GSTP gene expression in breast carcinomas. Br J Cancer 1998; 77:694-702.
46. Rybarova S, Hodorova I, Hajdukova M, Schmidtova K, Mojzis J, Kajo K, et al. Expression of MDR proteins in breast cancer and its correlation with some clinical and pathological parameters. Neoplasma 2006; 53:128-135.